Statement of Financial Position
| Assets | As of Dec. 31, 2018 |
|---|
| Cash |
$6,452,299 |
| Accounts receivable and other assets |
2,412,675 |
| Prepaid expenses |
1,040,329 |
| |
|
| Marketable securities, at fair value |
|
| U.S. government securities |
21,043,680 |
| Corporate securities |
35,831,133 |
| Mutual and commingled funds |
8,144,994 |
| Total marketable securities |
65,019,807 |
| |
|
| Property and equipment, net of accumulated depreciation of $78,707,931 |
97,275,245 |
| total assets |
$172,200,355 |
| liabilities |
|
|---|
| Accounts payable and accrued expenses |
$3,934,759 |
|---|
| Notes payable |
1,100,000 |
| Liability for pension and post-retirement medical benefits |
11,265,223 |
| total liabilities |
16,299,982 |
| net assets |
|
| Net assets without donor restrictions |
155,900,373 |
| total net assets |
155,900,373 |
| total liabilities and net assets |
$172,200,355 |
This information was derived from Noble Research Institute’s annual financial statements for 2018, which were audited by the independent accounting firm of Grant Thornton LLP. A complete picture of Noble Research Institue’s financial position and results of operations can only be obtained by reviewing the annual financial statements in their entirety. Please contact Noble Research Institute if you would like a copy of the complete financial statements.
Statement of Activities and Changes in Net Assets
| net assets without donor restrictions |
Year Ended 2018 |
|---|
| Revenues, gains and losses: |
|
| Interest |
$14,001 |
| Dividends |
340,158 |
| Net realized gains on investments |
80,865 |
| Net unrealized loss on investments |
(86,907) |
| Grant and contribution revenue |
201,000 |
| Other miscellaneous program income |
6,349,483 |
| total revenues, gains and losses |
6,898,600 |
| |
|
| Program service expenses: |
|
| Research |
47,211,738 |
| Consultation and education |
11,191,306 |
| Total program service expenses |
58,403,044 |
| |
|
| Operational support |
3,815,107 |
| Provision for federal and state taxes |
(117,066) |
| total expenses |
62,101,085 |
| |
|
| Expenses in excess of revenues, gains and losses |
(55,202,485) |
| |
|
| Gain on involuntary conversion |
34,292,781 |
| Pension and postretirement medical related charges other than net periodic costs |
9,523,712 |
| change in net assets from operations |
(11,385,992) |
| net assets, beginning of year |
167,286,365 |
| net assets, end of year |
$155,900,373 |
